| Professional Pharmacy | |
| 9106 Philadelphia Rd, St 100, Rosedale, Maryland 21237 | |
| (410) 687-8113 |
| Name | Professional Pharmacy |
|---|---|
| Organization Name | Steen Pharmacy Llc |
| Location | 9106 Philadelphia Rd, St 100, Rosedale, Maryland 21237 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (410) 687-8113 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
As Bahrain implements reforms following protests that started last year, a significant number of patients – from all political and religious backgrounds - continue to avoid seeking medical care in public hospitals due to perceived discrimination, harassment, and ill treatment, the international medical humanitarian organisation Médecins Sans Frontières said today.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
At the study hospital, pediatric palliative care (PPC) involvement for children with VADs has sharply increased in recent years, according to the new research by Christopher Knoll, MD, and colleagues of Lucile Packard Children's Hospital Stanford, Palo Alto, Calif.
› Verified 3 days ago
| NPI Number | 1023178589 |
| Organization Name | JOHN WAYNE PHARMACY LLC |
| Doing Business As | PROFESSIONAL PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 9106 Philadelphia Rd, Baltimore, MD 21237 |
| Phone Number | 410-687-8113 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
As Bahrain implements reforms following protests that started last year, a significant number of patients – from all political and religious backgrounds - continue to avoid seeking medical care in public hospitals due to perceived discrimination, harassment, and ill treatment, the international medical humanitarian organisation Médecins Sans Frontières said today.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
At the study hospital, pediatric palliative care (PPC) involvement for children with VADs has sharply increased in recent years, according to the new research by Christopher Knoll, MD, and colleagues of Lucile Packard Children's Hospital Stanford, Palo Alto, Calif.
› Verified 3 days ago
| NPI Number | 1043781578 |
| Organization Name | STEEN PHARMACY, LLC |
| Type | Long Term Care Pharmacy |
| Address | 9106 Philadelphia Rd Ste 100, Rosedale, MD 21237 |
| Phone Number | 141-068-7811 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
As Bahrain implements reforms following protests that started last year, a significant number of patients – from all political and religious backgrounds - continue to avoid seeking medical care in public hospitals due to perceived discrimination, harassment, and ill treatment, the international medical humanitarian organisation Médecins Sans Frontières said today.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
At the study hospital, pediatric palliative care (PPC) involvement for children with VADs has sharply increased in recent years, according to the new research by Christopher Knoll, MD, and colleagues of Lucile Packard Children's Hospital Stanford, Palo Alto, Calif.
› Verified 3 days ago
| NPI Number | 1134628860 |
| Organization Name | STEEN PHARMACY, LLC |
| Doing Business As | PROFESSIONAL PHARMACY |
| Type | Pharmacy |
| Address | 9106 Philadelphia Rd Ste 100, Rosedale, MD 21237 |
| Phone Number | 410-687-8113 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
As Bahrain implements reforms following protests that started last year, a significant number of patients – from all political and religious backgrounds - continue to avoid seeking medical care in public hospitals due to perceived discrimination, harassment, and ill treatment, the international medical humanitarian organisation Médecins Sans Frontières said today.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
At the study hospital, pediatric palliative care (PPC) involvement for children with VADs has sharply increased in recent years, according to the new research by Christopher Knoll, MD, and colleagues of Lucile Packard Children's Hospital Stanford, Palo Alto, Calif.
› Verified 3 days ago
| NPI Number | 1457394108 |
| Organization Name | JOHN WAYNE PHARMACY LLC |
| Doing Business As | PROFESSIONAL PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 9106 Philadelphia Rd, Ste 100, Baltimore, MD 21237 |
| Phone Number | 410-687-8113 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
As Bahrain implements reforms following protests that started last year, a significant number of patients – from all political and religious backgrounds - continue to avoid seeking medical care in public hospitals due to perceived discrimination, harassment, and ill treatment, the international medical humanitarian organisation Médecins Sans Frontières said today.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
At the study hospital, pediatric palliative care (PPC) involvement for children with VADs has sharply increased in recent years, according to the new research by Christopher Knoll, MD, and colleagues of Lucile Packard Children's Hospital Stanford, Palo Alto, Calif.
› Verified 3 days ago
| NPI Number | 1568904613 |
| Organization Name | STEEN PHARMACY, LLC |
| Doing Business As | PROFESSIONAL PHARMACY |
| Type | Community/Retail Pharmacy |
| Address | 9106 Philadelphia Rd, Ste 100, Baltimore, MD 21237 |
| Phone Number | 410-687-8113 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
As Bahrain implements reforms following protests that started last year, a significant number of patients – from all political and religious backgrounds - continue to avoid seeking medical care in public hospitals due to perceived discrimination, harassment, and ill treatment, the international medical humanitarian organisation Médecins Sans Frontières said today.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
At the study hospital, pediatric palliative care (PPC) involvement for children with VADs has sharply increased in recent years, according to the new research by Christopher Knoll, MD, and colleagues of Lucile Packard Children's Hospital Stanford, Palo Alto, Calif.
› Verified 3 days ago
| NPI Number | 1801369335 |
| Organization Name | STEENPHARMACY LLC |
| Type | Pharmacy |
| Address | 9106 Philadelphia Rd Ste 100, Rosedale, MD 21237 |
| Phone Number | 141-068-7811 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
As Bahrain implements reforms following protests that started last year, a significant number of patients – from all political and religious backgrounds - continue to avoid seeking medical care in public hospitals due to perceived discrimination, harassment, and ill treatment, the international medical humanitarian organisation Médecins Sans Frontières said today.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
At the study hospital, pediatric palliative care (PPC) involvement for children with VADs has sharply increased in recent years, according to the new research by Christopher Knoll, MD, and colleagues of Lucile Packard Children's Hospital Stanford, Palo Alto, Calif.
› Verified 3 days ago
| NPI Number | 1972074417 |
| Organization Name | STEEN PHARMACY, LLC |
| Type | Community/Retail Pharmacy |
| Address | 9106 Philadelphia Rd Ste 100, Rosedale, MD 21237 |
| Phone Number | 141-068-7811 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
As Bahrain implements reforms following protests that started last year, a significant number of patients – from all political and religious backgrounds - continue to avoid seeking medical care in public hospitals due to perceived discrimination, harassment, and ill treatment, the international medical humanitarian organisation Médecins Sans Frontières said today.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
At the study hospital, pediatric palliative care (PPC) involvement for children with VADs has sharply increased in recent years, according to the new research by Christopher Knoll, MD, and colleagues of Lucile Packard Children's Hospital Stanford, Palo Alto, Calif.
› Verified 3 days ago
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
As Bahrain implements reforms following protests that started last year, a significant number of patients – from all political and religious backgrounds - continue to avoid seeking medical care in public hospitals due to perceived discrimination, harassment, and ill treatment, the international medical humanitarian organisation Médecins Sans Frontières said today.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
At the study hospital, pediatric palliative care (PPC) involvement for children with VADs has sharply increased in recent years, according to the new research by Christopher Knoll, MD, and colleagues of Lucile Packard Children's Hospital Stanford, Palo Alto, Calif.
› Verified 3 days ago
Medstar Pharmacy (store #2) Type: Medicare Supplier Location: 9103 Franklin Square Dr, Rosedale, Maryland 21237 Phone: (443) 777-6201 | |
Walgreens #6396 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8606 Philadelphia Rd, Rosedale, Maryland 21237 Phone: (410) 238-7705 | |
Medstar Pharmacy Store # 12 Type: Community/Retail Pharmacy Location: 9000 Franklin Square Dr, Rosedale, Maryland 21237 Phone: (443) 777-7400 | |
Professional Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9106 Philadelphia Rd, Rosedale, Maryland 21237 Phone: (410) 687-8113 | |
Americoast Maryland Llc Type: DME Supplier - Parenteral & Enteral Nutrition Location: 9321 Philadelphia Rd, Rosedale, Maryland 21237 Phone: (410) 918-0616 |